Skip to content
Search

Latest Stories

The silent emotional side effect of Mounjaro jabs users are just beginning to talk about

Mounjaro’s lesser-known psychological impact

Mounjaro side effects

Social media has recently drawn attention to the psychological challenges

iStock

Highlights

  • Mounjaro (tirzepatide) is a diabetes drug also prescribed for weight loss
  • Users report emotional side effects, including low motivation and feeling “stuck”
  • A TikTok post describing the “slow middle” of weight loss struck a chord with others
  • The injection can support weight loss of up to 20% over a year
  • Drug is now sold in UK supermarkets including Tesco and Morrisons


While Mounjaro has become increasingly popular for aiding weight loss, users have begun highlighting a less-discussed side effect — an emotional downturn midway through treatment.

The medication, also known by its generic name tirzepatide, is a weekly injection originally developed to manage type 2 diabetes. It has since gained traction for its weight loss benefits, with some patients shedding up to 20% of their body weight over the course of a year.


Now available in UK supermarket pharmacies, including Tesco and Morrisons, Mounjaro is being used more widely — but not all side effects are physical.

TikTok user describes the “slow middle” struggle

Social media has recently drawn attention to the psychological challenges that can emerge partway through treatment. TikTok creator @Swedish_Sandra described feeling emotionally flat and demotivated despite ongoing physical progress.

“It’s the period of time between the before and after photos,” she explained in a recent post. “This phase feels quiet — not the start, not the finish, just the slow middle where everything is shifting but the big change isn’t visible yet.”

Sandra encouraged others to recognise that this emotional plateau is part of the journey, calling it “the hardest bit mentally” and stressing the importance of patience and perseverance.

Users share similar experiences

Sandra’s experience resonated with many who commented on her post, saying they too had noticed a dip in motivation once the initial rapid weight loss slowed.

“I’ve been struggling for the last month wondering if all this money is worth it,” wrote one user.
“My weight loss has stalled too,” added another. “It is hard to get used to when you’re used to big drops at the start.”

Several commenters offered support and perspective, with one noting:

“Even a quarter of a pound a week is still a loss. This is the phase where the weight lost is likely fat, not just water. That’s real progress.”

Sandra responded:

“The initial excitement has died down, but those ‘boring’ moments are where the steady, lasting change happens.”

A reminder that weight loss is not linear

While Mounjaro has proven effective for weight loss, the emotional and mental health aspects of the process are increasingly part of the conversation. Users are calling for greater openness around the slower, less visible phases of the journey.

The drug remains a significant tool for people managing obesity or type 2 diabetes, but the growing number of personal accounts highlight the importance of setting realistic expectations and maintaining emotional resilience throughout treatment.

More For You

AI heart disease detection

ECG readings similar to those produced by an Apple Watch

iStock

AI system using Apple Watch-style ECG shows strong accuracy in detecting heart disease

Key points

  • Yale researchers trial AI tool that reads single-lead ECG data similar to that captured by an Apple Watch
  • Early results suggest around 92% accuracy compared with hospital-grade tests
  • System could support earlier screening for structural heart disease, but more research is needed

A smartwatch could one day help detect serious heart conditions earlier, after researchers reported promising results from an artificial intelligence tool designed to analyse ECG readings similar to those produced by an Apple Watch.

What the study looked at

Diagnosing structural heart disease, which includes problems such as damaged valves, thickened heart muscle and reduced pumping function, typically requires specialist equipment such as an echocardiogram. Smartwatches already offer single-lead ECG readings, but these are generally limited to identifying rhythm issues like atrial fibrillation.

Keep ReadingShow less